Evaluation of the efficacy (wound epithelialization and time to closure) and safety (emergence and nature of adverse event) of a lite compression system versus a tubular bandage in the local treatment of mixed leg ulcers: prospective multicenter, randomized controlled, open-label french clinical study
This is a prospective, randomized, controlled, open-label, multicenter clinical trial conducted in patients with a mixed (non-ischemic) leg ulcer of stage C6 / C6r of the CEAP classification. This study is carried out in around 50 French investigational centers. A total of 210 patients meeting the eligibility criteria will be included. The patients will be followed for 16 weeks and a total of 6 clinical evaluations will be carried out by the investigating centers. A planimetric survey of the studied leg ulcers is carried out during the initial assessment of the wound (Day 0) and at each assessment provided for in the protocol (Week 2, Week 4, Week 8 and Week 12). A QoL is carried out at D0 and end of the study for each patient included in the protocol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
210
Treatment with light compression system during 16-week treatment period (6 medical visits are planned: D0, W2, W4, W8, W12, W16)
Etiological treatment of mixed leg ulcer stage C6 / C6r of the CEAP classification
Patricia SENET, Paris, Paris 75000
Paris, Paris, France
NOT_YET_RECRUITINGCabinet d'Angiologie - Médecine Vasculaire 377 rue Garibaldi 69007 LYON
Lyon, France
RECRUITINGAPHP Hopital TENON Service de Dermatologie et médecine vasculaire 4 Rue de la Chine 75970 PARIS Cedex 20
Paris, France
NOT_YET_RECRUITINGComplete closure of the Venous Leg Ulcer (VLU)
Description: Complete closure of the leg ulcer is defined by 100% re-epithelialization of the mixed Leg Ulcer (MLU)
Time frame: 16-week treament period
Time to complete closure of the Venous Leg Ulcer (VLU)
Description: Time to complete closure of the Mixed Leg Ulcer (MLU) is defined as the time from inclusion to the date of complete closure
Time frame: 16-week treament period
Safety analysis
Nature and number of adverse event related to the use of the studied light compression system and tubular bandage (serious/ non-serious and emergent)
Time frame: 16-week treament period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.